Predictive mathematical model of mortality for community acquired pneumonia
Abstract
Background: pneumonia acquired in the community constitutes an important problem worldwide. It is the fourth cause of death at our country. Prognoses index are helpful to detect the patients with high risk of death, however these prognoses have low sensibility and specificity.
Objective: to propose a predictive mathematical mortality model for acquired pneumonia disease in the community.
Methods: a longitudinal analytic study with two groups was conducted. Mann Withney's test was made to obtain predictive variables of mortality. Pearson correlation was calculated with meaningful variables. Then, a mathematical model was elaborated and was taken to ROC curve to find the curve area as well as coordinates. Sensibility and specificity were calculated.
Results: age from 79± 11 years with 50 % accounting for females. Global mortality was 35%. The variables with different behavior between the two groups were systolic blood pressure (x2=0,001) and diastolic blood pressure (x2=0,001), Creatinine was (x2=0, 03), respiratory frequency rate (x2=0, 01), pressure of oxygen (x2=0,036) just like the numbers of hemoglobin, and finally the level of potassium (K) (x2=0,004) with marked difference between groups.
Conclusions: this mathematical model is a useful tool to evaluate the patient's state because it helps to give a more precise diagnostic.
DeCS: PNEUMONIA; MATHEMATICAL MODELS; SENSITIVITY AND SPECIFICITY; CAUSALITY; LONGITUDINAL STUDIES.
Downloads
References
1.Sharma S, Sneath E, Cheng A, Friedman N. Community-acquired syndromes causing morbidity and mortality in Australia.Commun Dis Intell Q Rep [Internet]. 2017 Mar[cited 2017 May 8];31;41(1):[about 5 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC28385138/.
2.Caggiano S, Ullmann N, De Vitis E, Trivelli M, Mariani C. Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania.Int J Mol Sci [Internet]. 2017 Mar 13 [cited 2017 May 8];18(3):[about 4 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC28335406/.
3.Sparham S, Charles P. Controversies in diagnosis and management of community-acquired pneumonia.Med J Aust [Internet]. 2017 Apr 17[cited 2017 may 8];206(7):[about 4 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28403766
4.Infomed [Internet]. La Habana: Anuario Estadístico de Salud. 2012; 2013 [actualizado 2017 Mar 12; citado 2017 May 25]. Cuadro 14. Principales causas de muerte en todas las edades. 2000, 2012-2013 [aprox. 2 p]. Disponible en: http://www.sld.cu/sitios/dne/.
5.Khan F, Owens M, Restrepo M, Povoa P, Martin-Loeches I. Tools for outcome prediction in patients with community acquired pneumonia.Expert Rev Clin Pharmacol [Internet]. 2017 Feb[cited 2017 May 8];10(2):[about 9 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27911103/.
6.Pilotto A, Dini S, Daragjati J, Miolo M, Mion M. Combined use of the multidimensional prognostic index (MPI) and procalcitonin serum levels in predicting 1-month mortality risk in older patients hospitalized with community-acquired pneumonia (CAP): a prospective study.Aging Clin Exp Res [Internet]. 2017 Apr 17 [cited 2017 May 25]:30(2):[about 4 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28417242
7.Chang P, Tsao S, Chang J, Chien M, Hung W, Huang Y, et al. Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia.Clin Chim Acta [Internet]. 2016 Dec 1[cited 2017 May 8];463:[about 6 p.].Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27983998/.
8.Kim J, Hong D, Lee K, Kim S, Baek K, Park S. Usefulness of plasma neutrophil gelatinase-associated lipocalin concentration for predicting the severity and mortality of patients with community-acquired pneumonia.Clin Chim Acta [Internet]. 2016 Nov [cited 2017 May 8];(462):[about 5 p.].Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27662812/.
9.Lee J, Kim Y. Predictive factors of true bacteremia and the clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia.Medicine (Baltimore) [Internet]. 2016 Oct [cited 2017 May 8];95(41):[about 2 p.] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27741119/.
10.Cárdenas Cruz A, Roca Guiseris J. Tratado de Medicina Intensiva. Segunda ed. Barcelona, España: Elsevier; 2017.
11.Noguchi S, Yatera K, Kawanami T, Fujino Y, Moro H, Aoki N, et al. Pneumonia Severity Assessment Tools for Predicting Mortality in Patients with Healthcare-Associated Pneumonia: A Systematic Review and Meta-Analysis. Respiration [Internet]. 2017 Apr 28 [cited 2017 May 25];93(6):[about 9 p.] Available from: https://www.ncbi.nlm.nih.gov/pubmed/28449003
12.Lenz H, Norby G, Dahl V, Ranheim T, Haagensen R. Five-year mortality in patients treated for severe community-acquired pneumonia -a retrospective study.Clin Microbiol Infect [Internet]. 2017 Apr [cited 2017 May 25];23(4):[about 8 p.] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC28164259/.
13.Vardakas K, Trigkidis K, Falagas M. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.Clin Microbiol Infect [Internet] 2017 Apr [cited 2017 May 8];23(4):[about 7 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27965070/.
14.Rhedin S, Galanis I, Granath F, Ternhag A, Hedlund J, Spindler C. Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study.Clin Microbiol Infect [Internet]. 2017 Apr [cited 2017 May 8];23(4):[about 7 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC28017793/.
15.Wu J, Jin Y, Li H, Xie Z, Li J, Ao Y, et al. Evaluation and significance of C-reactive protein in the clinical diagnosis of severe pneumonia.Exp Ther Med [Internet] 2015 Jul [cited 2017 Jun 7];10(1):[about 5 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26170931
16.Andersen S, Baunbæk Egelund G, Jensen A, Petersen P, Rohde G, Ravn P. Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia.Infect Dis (Lond) [Internet]. 2017 Apr [cited 2017 May 8];49(4):[about 9 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27887037/.
17.Alarcón Á, Lagos I, Fica A. Gastos hospitalarios por neumonía neumocóccica invasora en adultos en un hospital general en Chile.Rev Chilena Infectol [Internet]. 2016 Aug.[cited 2017 May 25];33(4):[about 5 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27905622
18.Egelund G, Jensen A, Andersen S, Petersen P, Lindhardt B, von Plessen C. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study.BMC Pulm Med [Internet]. 2017 Apr [cited 2017 May 25] 20;17(1):[about 3 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28427381
19.Turktan M, Ak O, Erdem H, Ozcengiz D, Hargreaves S. Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey.Int J Infect Dis [Internet]. 2017 May [cited 2017 May 25];58: [about 3 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28419820
20.Kilic A, Ohkuma R, Grimm J, Magruder J, Sussman M, Schneider E, et al. A novel score to estimate the risk of pneumonia after cardiac surgery.J Thorac Cardiovasc Surg [Internet]. 2016 May [cited 2017 jun 7];151(5):[about 5 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27085620
21.Strobel R, Liang Q, Zhang M, Wu X, Rogers M, Theurer P. A Preoperative Risk Model for Postoperative Pneumonia After Coronary Artery Bypass Grafting.Ann Thorac Surg [Internet]. 2016 Oct [cited 2017 Jun 7];102(4):[about 8 p.].Available from: https://www.ncbi.nlm.nih.gov/pubmed/27261082
22.Hernández-Cárdenas C, Serna-Secundino H, García-Olazarán J, Aguilar-Pérez C, Rocha-Machado J, Campos-Calderón L, et al. Acute Respiratory Distress Syndrome Secondary to Influenza A(H1N1)pdm09: Clinical Characteristics and Mortality Predictors.Rev Invest Clin [Internet]. 2016 Sep-Oct [cited 2017 Jun 7];68(5):[about 11 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27941959
23.Gordo-Remartínez S, Calderón-Moreno M, Fernández-Herranz J, Castuera-Gil A. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.PLoS One [Internet]. 2015 Jun 1[cited 2017 Jun 7];10(6):[about 8 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26030588
24.Tokman S, Barnett C, Jarlsberg L, Taub P, den Boon S. Procalcitonin predicts mortality in HIV-infected Ugandan adults with lower respiratory tract infections.Respirology [Internet]. 2014 Apr [cited 2017 Jun 7];19(3):[about 6 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24460728
25.De Santis O, Kilowoko M, Kyungu E, Sangu W, Cherpillod P, Kaiser L, et al. Predictive value of clinical and laboratory features for the main febrile diseases in children living in Tanzania: A prospective observational study.PLoS One [Internet]. 2017 May 2 [cited 2017 Jun 7];12(5):[about 8 p.]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28464021
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025